Baxter International Inc Investor Call Transcript
Good morning, everyone, and thank you for joining us on such short notice for Baxter's investor update. We are very excited to share with you the next phase of Baxter's transformation journey following a comprehensive strategic review we conducted over the last several months.
Joining me today are Joe Almeida, Baxter's Chairman and Chief Executive Officer; and Jay Saccaro, Baxter's Chief Financial Officer. On today's call, we will be discussing Baxter's proposed spinoff of the Renal Care and Acute Therapies global business units, Baxter's planned organizational redesign and further details surrounding actions to enhance our capital allocation profile including the review of strategic alternatives involving our BioPharma Solutions or BPS business.
We are excited to share with you the strategic rationale behind our plan to create 2 independent, leading healthcare companies and how we believe the spin will further enable strategic clarity and business simplification to accelerate each company's growth potential and deliver enhanced
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |